Atsena Therapeutics has started dosing in the second of four cohorts in the Phase I/II trial. Image credit: Shutterstock / Marko Aliaksandr. Atsena Therapeutics has announced positive preliminary data ...
Some results have been hidden because they may be inaccessible to you